– Significant pipeline progress with potentially first- or best-in-class drug candidates – Strong cash position of $1.1 billion as of December 31, 2020 SAN DIEGO–(BUSINESS WIRE)–Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2020. “This […]
Other News
Evasc Neurovascular Announces First Neuro Product Approved in French Forfait Innovation Program
VANCOUVER, British Columbia–(BUSINESS WIRE)–Evasc Neurovascular is proud to announce its successful application to France’s Ministry of Health (Haute Autorité de la Santé, HAS) Forfait Innovation (FI) program for the eCLIPs™ device, published in its official journal December 23, 2020 – https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000042722732. The Forfait Innovation program grants clinical trial funding to evaluate […]
Medtronic Reports Third Quarter Fiscal 2021 Financial Results
– Q3 Revenue of $7.8 Billion Increased 0.8% as Reported and Decreased 1.0% Organically – Q3 GAAP Diluted EPS of $0.94; Q3 Non-GAAP Diluted EPS of $1.29 DUBLIN, Feb. 23, 2021 /PRNewswire(opens new window)/ — Medtronic plc (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2021, which ended January 29, 2021. The company reported […]
Inovise Receives Breakthrough Device Designation for Novel Non-Invasive System to Remotely Monitor Risk of Decompensation in Heart Failure Patients
PORTLAND, Ore., Feb. 23, 2021 /PRNewswire/ — Inovise Medical today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its AUDICOR® heart failure management system. The system uses clinically tested algorithms to detect the risk of decompensation at home in patients who have been previously hospitalized for heart failure. […]
icometrix expands icobrain portfolio with ischemic stroke solution
LEUVEN, Belgium and BOSTON, Feb. 23, 2021 /PRNewswire/ — icometrix, world leader in imaging AI solutions for people with neurological conditions, announced the addition of icobrain cva, a stroke solution, to the icobrain portfolio. The announcement follows the FDA-clearance and CE-marking of its image processing software for the analysis and communication of the tissue perfusion state […]
Abbott announces approval in Brazil to use two heart devices that can save the lives of babies and children
The world’s smallest pediatric treatments, developed by Abbott, meet the needs of the most vulnerable patients: babies and children born with congenital heart defects Approval includes use of a pediatric mechanical heart valve and the first minimally invasive device to treat premature and newborn babies with an opening in the […]
BioCardia Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates
SAN CARLOS, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], today announced that it has entered into an agreement with a leading Japanese pharmaceutical company related to BioCardia Helix catheter biotherapeutic delivery product candidates. Under the terms of the agreement, BioCardia will receive a $500,000 up-front payment, a portion […]
FUJIFILM Sonosite deploys new Point-of-Care Ultrasound Workflow Management Solution at Kaweah Delta Medical Center’s Emergency Department
BOTHELL, Wash., Feb. 22, 2021 /PRNewswire/ — FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound solutions, announced today that Kaweah Delta Medical Center’s Emergency Department has gone live with Sonosite Synchronicity™, a comprehensive point-of-care ultrasound (POCUS) workflow solution. Sonosite Synchronicity software helps point-of-care clinicians meet administrative challenges by enabling standardized remote workflows […]
IMPULSE DYNAMICS RECEIVES APPROVAL TO SELL OPTIMIZER CCM DEVICES IN CHINA
NMPA Clears the Way for Impulse Dynamics to Deliver Hope for Heart Failure Population MARLTON, N.J., Feb. 22, 2021 (GLOBE NEWSWIRE) — Impulse Dynamics, a company dedicated to improving the lives of people with heart failure (HF), today announced that the National Medical Products Administration (NMPA) approved the application for […]
Bracco Announces U.S. FDA Approval of 20-Vial Configuration of LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use
20-vial pack provides a green packaging alternative and helps increase storage efficiency MONROE TOWNSHIP, N.J., Feb. 22, 2021 /PRNewswire/ — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world’s leading companies in the diagnostic imaging business, announced today that its ultrasound enhancing agent (UEA) LUMASON® (sulfur hexafluoride lipid-type […]



